FIXX News and Press, Homology Medicines Inc. From 11/09/23

Homology Medicines Inc. (FIXX) is expected to report $-0.42 for Q3 2023

2023-08-14 17:07:32 ET Homology Medicines press release ( NASDAQ: FIXX ): Q2 GAAP EPS of -$0.61. Revenue of $0.35M (-56.3% Y/Y). For further details see: Homology Medicines GAAP EPS of -$0.61, revenue of $0.35M

- Reported Encouraging Initial Data from First Cohort of Phase 1 Trial Evaluating Gene Editing Candidate HMI-103 in Adults with PKU - - Evaluating Strategic Options for the Company and Pipeline of Genetic Medicines, including HMI-103 - BEDFORD, Mass., Aug. 14, 2023 (GLOBE NE...

2023-07-28 09:05:11 ET More on Homology Medicines Homology announces peer-reviewed preclinical data publication on its AAVHSC16 capsid FDA lifts clinical hold on Homology Medicines' phenylketonuria trial Homology stock falls 11% as Canaccord cuts price target citing ...

2023-07-27 17:34:32 ET There’s something special about penny stocks . Even when the stock market is down, like it is today, you’re likely to find at least a handful exploding higher. Obviously, there’s plenty of risk that comes along with trading cheap stocks. But t...

Announced Today Encouraging Initial Clinical Data from First Dose Level of pheEDIT Trial Evaluating HMI-103 BEDFORD, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that it has completed a review of its...

Participant 1 Achieved Clinically Meaningful Reduction in Plasma Phe of Up to 99% Change from Baseline and Below the U.S. PKU Treatment Guideline Threshold (<360 μmol/L) * ; At 31 Weeks Post-Dose, Phe Level 319 μmol/L With a 59% Reduction from Baseline...

2023-06-16 10:08:10 ET Gainers: Oncorus ( ONCR ) +264% . Microbot Medical ( MBOT ) +24% . NeuBase Therapeutics ( NBSE ) +19% . Community Health Systems ( CYH ) +8% . Homology Medicines ( FIXX ) +4% . Losers: Panbela Therap...

- New Preclinical Data Demonstrated Ability to Re-Dose with AAVHSCs Across Viral Clades, Potentially Expanding Possibilities of Genetic Medicine Programs in the Future - - Presented Methods to Accelerate Identification of Genomic Sites that Result in Improved Homologous Recombinatio...

2023-05-11 17:20:20 ET Homology Medicines press release ( NASDAQ: FIXX ): Q1 GAAP EPS of -$0.50 beats by $0.04 . Revenue of $0.8M (flat Y/Y) misses by $0.21M . As of March 31, 2023, Homology had approximately $150.0 million in cash, cash equivalents and short-t...